CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 1 - 10 of 926
Study Number Lead Group Study Title CIRB Study Status
CCTG MA.39 NCIC CTG Tailor RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer Adult CIRB - Late Phase Emphasis Available to Open
E2902 ECOG A Phase III Randomized Study of Farnesyl Transferase Inhibitor R115777 in Acute Myeloid Leukemia (AML) Patients in Second or Subsequent Remission or in Remission After Primary Induction Failure or Patients over Age 60 in First Remission Adult CIRB - Late Phase Emphasis Completed
GOG-0219 GOG A Phase III; Randomized Trial of Weekly Cisplatin and Radiation Versus Cisplatin and Tirapazamine and Radiation in Stage IB2; IIA; IIB; IIIB; and IVA Cervical Carcinoma Limited to the Pelvis Adult CIRB - Late Phase Emphasis Completed
EA2187 ECOG-ACRIN A Phase 2 Study of Pevonedistat in Combination with Carboplatin and Paclitaxel in Advanced Intrahepatic Cholangiocarcinoma Adult CIRB - Late Phase Emphasis Available to Open
CALGB-90206 CALGB A Randomized Phase III Trial of Interferon Alfa-2B or Interferon Alfa-2B Plus Bevacizumab in Patients with Advanced Renal Carcinoma Adult CIRB - Late Phase Emphasis Completed
AMC-108 AMC Multicenter Phase II Study of Pomalidomide Monotherapy in Kaposi Sarcoma Adult CIRB - Late Phase Emphasis Available to Open
S1314 SWOG A Randomized Phase II Study of Co-Expression Extrapolation (COXEN) With Neoadjuvant Chemotherapy for Localized; Muscle-Invasive Bladder Cancer Adult CIRB - Late Phase Emphasis Available to Open
E1899 ECOG Phase III Randomized Trial for Evaluating Second Line Hormonal Therapy (Ketoconazole/Hydrocortisone) versus Docetaxel/Estramustine Combination Chemotherapy on Progression Free Survival in Asymptomatic Patients with a Rising PSA after Hormonal Therapy for Prostate Cancer Adult CIRB - Late Phase Emphasis Completed
S0500 SWOG A Randomized Phase III Trial to Test the Strategy of Changing Therapy Versus Maintaining Therapy for Metastatic Breast Cancer Patients Who Have Elevated Circulating Tumor Cell Levels at First Follow-Up Assessment Adult CIRB - Late Phase Emphasis Completed
S1702 SWOG A Phase II Study of Isatuximab (SAR650984) (NSC-795145) for Patients with Previously Treated AL Amyloidosis Adult CIRB - Late Phase Emphasis Available to Open
Displaying 1 - 10 of 926